The 20 Best Choroid Plexus Carcinoma Doctors Near Me

. Dr. Baer is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, and Retinal Artery Occlusion.

. Dr. Eberhart is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. Her top areas of expertise are Cataract, Coloboma of Optic Papilla, Coloboma of Optic Nerve, and Choroid Plexus Carcinoma.

. Dr. Khedr is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, and Retinal Artery Occlusion.

David Malkin practices in Toronto, Canada. Mr. Malkin is rated as an Elite expert by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Li-Fraumeni Syndrome, Choroid Plexus Carcinoma, Cerebral Ventricle Cancer, and Rhabdomyosarcoma.

Uri Tabori practices in Toronto, Canada. Mr. Tabori is rated as an Elite expert by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Glioma, Choroid Plexus Carcinoma, Gliomatosis Cerebri, and Cerebral Ventricle Cancer.

Christian Thomas practices in Hamm, Germany. Mr. Thomas is rated as an Elite expert by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Cerebral Ventricle Cancer, Choroid Plexus Carcinoma, Choroid Plexus Papilloma, Prostatectomy, and Lithotripsy.

. Dr. Magee is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Late-Onset Retinal Degeneration, and Retinal Vein Occlusion.

. Dr. Clark is rated as an Experienced provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Glaucoma, Cataract, Periorbital Cellulitis, and Dry Eye Syndrome.

. Dr. Kilty is rated as an Experienced provider by MediFind in the treatment of Choroid Plexus Carcinoma. Her top areas of expertise are Strabismus, Glaucoma, Blepharitis, and Esotropia.

. Dr. Reeves is rated as an Experienced provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Cataract, Dry Eye Syndrome, Interstitial Keratitis, and Choroid Plexus Carcinoma.

Jerry Liu is a Hematologist and an Oncologist in Crystal Lake, Illinois. Dr. Liu is rated as an Experienced provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, Anemia, and Bone Marrow Aspiration.

John Chu is an Ophthalmologist in Aurora, Illinois. Dr. Chu is rated as an Experienced provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Cataract, Ocular Hypertension (OHT), Glaucoma, and Meibomianitis.

Dr. Paul T. Finger has collected or discovered the latest and most advanced medical technologies for the diagnosis and treatment of ocular tumors and eye cancer.With great respect for collaboration, he works closely with you, your referring doctor and his associated specialists to provide the most excellent care possible.The New York Eye Cancer Center was designed to be a responsive and caring environment, we strive to be your and your doctor's first choice for eye cancer care.Dr. Finger is the Director of Ocular Tumor Services at the Manhattan Eye, Ear and Throat Hospital and teaches residents from the New York University School of Medicine.A world-recognized expert in radiation and surgical techniques to conserve the eye and vision; Dr. Finger has pioneered the use of palladium-103 plaque radiation for choroidal melanoma, 3D and high-frequency ultrasound to image intraocular tumors, and created this world-renowned web site. Dr. Finger publishes in the major clinical journals and lectures frequently at local, national and international meetings. He graduated from Tulane Medical School, the Manhattan Eye, Ear and Throat Hospital, and then completed specialty training in treatment of ocular tumors and orbital diseases.Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology and sees patients from all over the world.Dr Finger was a principal investigator for The Collaborative Ocular Melanoma Study. He Chaired the Ophthalmic Oncology Task Force that wrote the 2014 consensus guidelines for plaque radiationt therapy of choroidal melanoma and retinoblastoma for The American Brachytherapy Society. Dr. Finger was the clinical director for the Plaque Radiation Therapy (Task Group 129) of the American Association for Physicists in Medicine (AAPM). Dr. Finger is Chair of the Ophthalmic Oncology Task Group of The American Joint Committee on Cancer (AJCC) - International Union Against Cancer (UICC). The AJCC-UICC has created a universal language (TNM-classification) commonly used around the world to describe eye cancer.Dr. Finger has a particular interest in melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma, squamous carcinoma, metastatic cancer to the eye and orbital tumors.Dr. Finger has assembled a team to care for patients with eye tumors. By picking the best doctors from several institutions, his team includes the top radiation, medical and pediatric oncologists from several institutions in New York City.Dr. Finger has spent his career inventing and improving new methods of diagnosis and treatment for eye cancer:. Dr. Finger is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Iridectomy, and Vitrectomy.

I specialize in the diagnosis and treatment of patients with ocular tumors, including benign and malignant tumors of the eye. I have been working in this field for more than 20 years. Cancer of the eye is a rare disease, but once the tumor is found we begin the treatment process; the key is to be diagnosed and treated timely and correctly. My goal is to improve the prognosis of these rare eye diseases in terms of life, conservation of the eye and sight. There is a large team dedicated to ocular oncology at Duke Health. I work very closely with colleagues across Duke Eye Center and from Duke Cancer Center, specialists in children and adults, to develop the best diagnosis and treatment plans for patients suffering from cancer of the eye with the mission of providing optimal prognosis for life, eye and vision preservation. Dr. Materin is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Choroid Plexus Carcinoma.

Carol Shields is an Oncologist and an Ophthalmologist in Philadelphia, Pennsylvania. Dr. Shields is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. Her top areas of expertise are Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, Vitrectomy, and Iridectomy. Dr. Shields is currently accepting new patients.

Jack Cohen is an Ophthalmologist in Skokie, Illinois. Dr. Cohen is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Retinal Detachment, X-Linked Juvenile Retinoschisis, X-Linked Retinal Dysplasia, Age-Related Macular Degeneration (ARMD), and Vitrectomy.

Timothy Fuller is an Ophthalmologist in Athens, Texas. Dr. Fuller is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Melanoma of the Eye, Choroid Plexus Carcinoma, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration.

Chris Bergstrom is an Ophthalmologist in Greenville, South Carolina. Dr. Bergstrom is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Melanoma of the Eye, Choroid Plexus Carcinoma, Retinal Detachment, Metastatic Uveal Melanoma, and Vitrectomy. Dr. Bergstrom is currently accepting new patients.

James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy.

Dr. Tsai was born in New York City and raised in rural Wisconsin. Since leaving the north woods, he has crisscrossed the country for his education and training, consistently earning recognition along the way for exceptional achievement. He graduated Summa Cum Laude from Harvard University as a member of Phi Beta Kappa. As a student at the prestigious School of Medicine at Washington University in Saint Louis, Dr. Tsai's education was fully supported by a merit-based George Wilson Distinguished Student Scholarship. He earned his M.D. and graduated Alpha Omega Alpha with a Merck Manual Award – an award given to three graduates for outstanding academic achievement. He completed his internship at the University of California, San Francisco, before being awarded the Bank of America Giannini Foundation Medical Research Fellowship and the Knights Templar Eye Foundation Pediatric Ophthalmology Research Grant to spend two years in the Ocular Oncology Laboratory at UCSF developing improved methods of genetic testing for patients with retinoblastoma. He then headed east for his residency in ophthalmology at the Wilmer Eye Institute at Johns Hopkins, where he first met his future colleagues, Drs. Joel Pearlman, Rob Equi, and Margaret Chang. He then returned to UCSF to complete his clinical fellowship in ocular oncology in 2006-7.Dr. Tsai has served on the academic faculty at the Wilmer Eye Institute and at UCSF. He has published papers and presented work at national meetings on retinoblastoma, uveal melanoma, and intraocular lymphoma. He has also served as a peer-reviewer for several journals, including Ophthalmology and Archives of Ophthalmology. He is a member of the American Academy of Ophthalmology, the American Medical Association, and the American Society of Retina Specialists. He is a past President, Program Chair, and Secretary of the Alta Ophthalmology Society in Sacramento. He is board certified by the American Board of Ophthalmology.Aside from his mission to provide compassionate care for his patients, Dr. Tsai enjoys eating and he tries to compensate for this by indoor rock climbing and chasing after his two young children. On Sundays in the fall, he shows his Wisconsin roots as a die-hard Green Bay Packers fan.We provide exceptional care and compassionate service to optimize the vision of patients with retinal disease. Dr. Tsai is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Melanoma of the Eye, Choroid Plexus Carcinoma, Retinal Detachment, and Metastatic Uveal Melanoma.